Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP184909.RAWpZf1LpT5x7QHXBq0AG1XgJZAiieWgL8-yw3Q0FHu-g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP184909.RAWpZf1LpT5x7QHXBq0AG1XgJZAiieWgL8-yw3Q0FHu-g130_assertion type Assertion NP184909.RAWpZf1LpT5x7QHXBq0AG1XgJZAiieWgL8-yw3Q0FHu-g130_head.
- NP184909.RAWpZf1LpT5x7QHXBq0AG1XgJZAiieWgL8-yw3Q0FHu-g130_assertion description "[To evaluate the role of miRNA allelic variants in the susceptibility to familial breast and ovarian cancers in BRCA1/BRCA2-negative patients, we focused our attention on three miRNAs, miR-146a, miR-17 and miR-369, based on their affinity to either BRCA1 or BRCA2 messenger RNA and their localization on chromosome regions commonly deleted in those tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP184909.RAWpZf1LpT5x7QHXBq0AG1XgJZAiieWgL8-yw3Q0FHu-g130_provenance.
- NP184909.RAWpZf1LpT5x7QHXBq0AG1XgJZAiieWgL8-yw3Q0FHu-g130_assertion evidence source_evidence_literature NP184909.RAWpZf1LpT5x7QHXBq0AG1XgJZAiieWgL8-yw3Q0FHu-g130_provenance.
- NP184909.RAWpZf1LpT5x7QHXBq0AG1XgJZAiieWgL8-yw3Q0FHu-g130_assertion SIO_000772 20810544 NP184909.RAWpZf1LpT5x7QHXBq0AG1XgJZAiieWgL8-yw3Q0FHu-g130_provenance.
- NP184909.RAWpZf1LpT5x7QHXBq0AG1XgJZAiieWgL8-yw3Q0FHu-g130_assertion wasDerivedFrom gad-20150221 NP184909.RAWpZf1LpT5x7QHXBq0AG1XgJZAiieWgL8-yw3Q0FHu-g130_provenance.
- NP184909.RAWpZf1LpT5x7QHXBq0AG1XgJZAiieWgL8-yw3Q0FHu-g130_assertion wasGeneratedBy ECO_0000203 NP184909.RAWpZf1LpT5x7QHXBq0AG1XgJZAiieWgL8-yw3Q0FHu-g130_provenance.